Awakn Life Sciences Appoints Uk Leader In Addictions Psychiatry, Dr. Arun Dhandayudham, As Chief Medical Officer

Awakn Life Sciences has announced that Dr. Arun Dhandayudham is joining Awakn as its Chief Medical Officer. Dr. Ben Sessa is stepping back from his role as CMO to become Awakn’s Head of Psychedelic Medicine, allowing him to continue his work in research, academic and training activities, as well as a greater focus on the day-to-day treatment of his clients as the Lead Physiatrist for Awakn Clinics Bristol.

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account
Category Press Release
Published in Awakn Life Sciences
Country United Kingdom

Companies Featured

Awakn Life Sciences
AWAKN Life Sciences aims to bring psychedelics therapy to the UK. Under this company fall three arms; psychedelic research, clinic platform, and practitioner training.

People Featured

Ben Sessa
Ben Sessa is psychedelics researcher, psychotherapist, advocate for legalization, author, co-founder of Breaking Convention, and Chief Medical Officer at AWAKN Life Sciences.

Inline Feedbacks
View all comments